CellPly Company
Developing analytical systems to characterize next-generation cancer immunotherapy
Technology:
Biotechnology, Health Care, Medical
Industry:
Early Drug Development, Preclinical Development
Headquarters:
Bologna, Emilia-Romagna, Italy
Founded Date:
2013-01-01
Employees Number:
11-50
Funding Status:
Seed
Investors Number:
8
Total Funding:
6690000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-12-15
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership